H.R. 9495/S Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT)
Literal federal measure citations: H.R. 9495
2026 · 2nd Quarter (Apr 1 - June 30)
HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION
Filed by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 17, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Filing UUID
- 150d4e5a-c1fe-47ce-b4f5-fcda320c9a85
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R. 9260/S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.